Studies a cardiac scale to predict fluid overload in people on peritoneal dialysis
Explores a cardiac scale to predict fluid overload events in adults with kidney disease.
Key facts
- Who runs it
- Bodyport Inc.
- Where
- Augusta, Chicago, Nashville, and Victorville, United StatesSee the 4 sitesAlso in 1 other country, 3 sites
- Trial code
- Registry title
- Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
- Status
- Recruiting
- People taking part
- 125 people, planned
- Started
- 9 Sept 2025
- Expected to end
- Nov 2027
- Type of study
- Observational
- Treatments tested
- Bodyport Cardiac Scale
- Record updated
- 22 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with end-stage kidney disease who get automated peritoneal dialysis. It tests a scale that may warn of fluid build-up.
- Age
- 21 years or older
- Sex
- All sexes can join.
- Disease stage
- End-stage kidney disease treated with automated peritoneal dialysis.
- Earlier treatment
- Must be on automated peritoneal dialysis and followed on the Vantive Sharesource Remote Patient Management Platform.
Main reasons for not taking part
- Hemodialysis now or planned in the next 12 months
- Life expectancy under 12 months
- Pregnant or planning pregnancy in the next 12 months
- Weight above 375 lbs (170 kg)
- Kidney transplant planned in the next 12 months
This trial only enrols participants on dialysis. The registry sentence this rests on: Receiving automated peritoneal dialysis for the treatment of ESKD
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Age 21 years or older
- Able to speak and read English, or able to speak and read Spanish and has a caregiver or family member who speaks English and can provide assistance
- Able to stand on two bare feet unassisted
- Receiving automated peritoneal dialysis for the treatment of ESKD
- Followed on the Vantive Sharesource Remote Patient Management Platform
Who cannot take part
- Planned kidney transplant within the next 12 months
- Undergoing or plan to undergo hemodialysis in the next 12 months
- Have a life expectancy of less than 12 months
- Are pregnant or plan to become pregnant during the next 12 months
- Weigh greater than 375 lbs
- Have an implanted neurostimulator system
Where in United States
Also in 1 other country, 3 sites
- Southeastern Clinical Research InstituteAugusta, United StatesContact: Meredith PrichardTaking people
- Northwestern UniversityChicago, United StatesContact: Alexis StevensonTaking people
- Vanderbilt University Medical CenterNashville, United StatesContact: Dr. Kerri CavanaughTaking people
- Desert Cities DialysisVictorville, United StatesContact: Heberto SchrammTaking people
About the trial
What the trial wants to find out
To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.
The group in the trial
- PD Patients
Patients with kidney disease on peritoneal dialysis.
Treatment: Bodyport Cardiac Scale
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Sensor-based Congestion Alert for Events in Peritoneal Dialysis (SCALE-PD)
- Plain-language title
- Studies a cardiac scale to predict fluid overload in people on peritoneal dialysisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 22 October 2026